Literature DB >> 33139077

A patient with COVID-19 and anti-glomerular basement membrane disease.

Neriman Sila Koc1, Tolga Yildirim2, Arzu Saglam3, Mustafa Arici2, Yunus Erdem2.   

Abstract

Year:  2020        PMID： 33139077      PMCID： PMC7543891          DOI： 10.1016/j.nefro.2020.08.003

Source DB:  PubMed          Journal:  Nefrologia (Engl Ed)        ISSN： 2013-2514


× No keyword cloud information.
  9 in total

1.  Goodpasture's syndrome associated with influenza A2 virus infection.

Authors:  C B Wilson; R C Smith
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

Review 2.  [Review on anti-glomerular basement membrane disease or Goodpasture's syndrome].

Authors:  C Marques; E Plaisier; P Cacoub; J Cadranel; D Saadoun
Journal:  Rev Med Interne       Date:  2019-11-24       Impact factor: 0.728

3.  COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?

Authors:  Michelle Willicombe; David Thomas; Stephen McAdoo
Journal:  J Am Soc Nephrol       Date:  2020-04-20       Impact factor: 10.121

4.  A "Mini-Epidemic" of anti-glomerular basement membrane disease: Clinical and epidemiological study.

Authors:  Umesh Lingaraj; Shivaprasad Sasivehalli Mallappa; Rajiv Elkal Neminah; Satishkumar Madakala Mohan; Leelavathi Venkatesh; Sreedhara Chikkanayakanahalli Gurusiddaiah; Niranjan Manibally Rachaiah
Journal:  Saudi J Kidney Dis Transpl       Date:  2017 Sep-Oct

5.  Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.

Authors:  Lorenzo D'Antiga
Journal:  Liver Transpl       Date:  2020-04-24       Impact factor: 5.799

6.  Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.

Authors:  Hua Su; Ming Yang; Cheng Wan; Li-Xia Yi; Fang Tang; Hong-Yan Zhu; Fan Yi; Hai-Chun Yang; Agnes B Fogo; Xiu Nie; Chun Zhang
Journal:  Kidney Int       Date:  2020-04-09       Impact factor: 10.612

7.  The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts.

Authors:  Matthew J Memoli; Rani Athota; Susan Reed; Lindsay Czajkowski; Tyler Bristol; Kathleen Proudfoot; Rachel Hagey; Jocelyn Voell; Charles Fiorentino; Angela Ademposi; Shmuel Shoham; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2013-11-01       Impact factor: 9.079

8.  Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

Authors:  Sara Monti; Silvia Balduzzi; Paolo Delvino; Elisa Bellis; Verdiana Serena Quadrelli; Carlomaurizio Montecucco
Journal:  Ann Rheum Dis       Date:  2020-04-02       Impact factor: 19.103

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.